Integrated Report

Overview

The report highlights Towa Pharmaceutical's efforts to enhance corporate value through stable supply of generics, human capital management, and environmental initiatives. It details the company's value creation process and the 5th Mid-term Business Plan 2021-2023. The report also covers the company's financial and non-financial performance, including production capacity expansion and sustainability efforts. The company aims to be a comprehensive healthcare company for the era of the 100-year life.

Document

Report type: Integrated Report
Class: Embedded
Scope: Full report
Fiscal year: 2022
Period: 1 April 2022 – 31 March 2023
Language: English
Pages
File size

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP

Materiality

Assessment

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services